2,4-dichloro-6-[(2S)-2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]-1,3,5-triazine
Structure Info
- Chemspace ID
- CSSB21332130099 (In-Stock Building Blocks)
- IUPAC Name
- 2,4-dichloro-6-[(2S)-2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]-1,3,5-triazine
- Mol formula
- C10H10Cl2N6O
- Mol weight
- 301 Da
- Catalog Number(s)
- BBLS21332130099, BBV-2181268190, EN300-54987170, bbls21332130099
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.98
- Heavy atoms count
- 19
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.5
- Polar surface area (Å)
- 81
- Hydrogen bond acceptors count
- 6
- Hydrogen bond donors count
- 0
![Chemical structure of 2,4-dichloro-6-[(2S)-2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]-1,3,5-triazine (C10H10Cl2N6O) - CSSB21332130099](/st/structure/200/252393df0de9d4272d76da0080e3daf4/CC1%253DNN%253DC%2528O1%2529%255BC%2540%2540H%255D1CCCN1C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png "C10H10Cl2N6O")
- Zoom the structure
- CSSB21332130099
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 888.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 930.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 972.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 1,014.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 1,057.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 2,071.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 3,065.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 4,545.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 2,4-dichloro-6-[2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]-1,3,5-triazine - CSSB02214498099](/st/structure/200/7e4e7b5181b2d945f131e1c93a28691a/CC1%253DNN%253DC%2528O1%2529C1CCCN1C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2,4-dichloro-6-[(2R)-2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]-1,3,5-triazine - CSSB21332130100](/st/structure/200/ce22dfc07fc26651b3f061293ec25790/CC1%253DNN%253DC%2528O1%2529%255BC%2540H%255D1CCCN1C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2,4-dichloro-6-[2-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]-1,3,5-triazine - CSSB21332060039](/st/structure/200/a1304de805537e71cf5d295a9e31d5b8/CC1%253DNN%253DC%2528O1%2529C1CCCCN1C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2,4-dichloro-6-[3-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]-1,3,5-triazine - CSSB21332129395](/st/structure/200/a42c32ddd6e8d593a75c194d356808f9/CC1%253DNN%253DC%2528O1%2529C1CCCN%2528C1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1.png)
![Chemical structure of 2,4-dichloro-6-[(2R,4S)-4-methoxy-2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]-1,3,5-triazine - CSSB21332154310](/st/structure/200/011c816087b94a7b85db1f49b982c7c9/CO%255BC%2540H%255D1C%255BC%2540%2540H%255D%2528N%2528C1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1%2529C1%253DNN%253DC%2528C%2529O1.png)
![Chemical structure of 2,4-dichloro-6-[(2R,4R)-4-methoxy-2-(5-methyl-1,3,4-oxadiazol-2-yl)pyrrolidin-1-yl]-1,3,5-triazine - CSSB21332154311](/st/structure/200/660d5c7d9034bbc3f4bd4abc6bf0accc/CO%255BC%2540%2540H%255D1C%255BC%2540%2540H%255D%2528N%2528C1%2529C1%253DNC%2528Cl%2529%253DNC%2528Cl%2529%253DN1%2529C1%253DNN%253DC%2528C%2529O1.png)
